Brompton Funds Declare Distributions

TORONTO, Jan. 22, 2021 (GLOBE NEWSWIRE) -- (TSX: BDIV, BFIN, BFIN.U, BLOV, BPRF, BPRF.U, BREA, EDGF, HIG, HIG.U) – Brompton Funds announces monthly distributions for record dates from January to March 2021 for each of the following exchange-traded funds (“ETFs”):

	Ticker	Amount Per Unit
Brompton Global Dividend Growth ETF	BDIV	Cdn$	0.10
Brompton North American Financials Dividend ETF	BFIN	Cdn$	0.08333
	BFIN.U	US$	0.08333
Brompton North American Low Volatility Dividend ETF	BLOV	Cdn$	0.06667
Brompton Flaherty & Crumrine Investment Grade Preferred ETF	BPRF	Cdn$	0.10417
	BPRF.U	US$	0.10417
Brompton Global Real Assets Dividend ETF	BREA	Cdn$	0.08333
Brompton European Dividend Growth ETF	EDGF	Cdn$	0.0416
Brompton Global Healthcare Income & Growth ETF	HIG	Cdn$	0.05
	HIG.U	US$	0.05

Record Dates and Payment Dates are as follows:

Record Date	Payment Date
January 29, 2021	February 12, 2021
February 26, 2021	March 12, 2021
March 31, 2021	April 15, 2021

Unitholders are reminded that the ETFs offer distribution reinvestment plans (“DRIP”) which provide unitholders with the ability to automatically reinvest distributions, commission free, and realize the benefits of compound growth. Unitholders can enroll in a DRIP program by contacting their investment advisor. The ETFs offer a DRIP for Canadian dollar denominated units only.

About Brompton FundsFounded in 2000, Brompton is an experienced investment fund manager with income focused investment solutions including TSX traded closed-end funds and exchange-traded funds. For further information, please contact your investment advisor, call Brompton’s investor relations line at 416-642-6000 (toll-free at 1-866-642-6001), email [email protected] or visit our website at www.bromptongroup.com.

Commissions, trailing commissions, management fees and expenses all may be associated with exchange-traded fund investments.  Please read the prospectus before investing.  Exchange-traded funds are not guaranteed, their values change frequently and past performance may not be repeated.

Certain statements contained in this document constitute forward-looking information within the meaning of Canadian securities laws. Forward-looking information may relate to matters disclosed in this document and to other matters identified in public filings relating to the ETFs, to the future outlook of the ETFs and anticipated events or results and may include statements regarding the future financial performance of the ETFs. In some cases, forward-looking information can be identified by terms such as “may”, “will”, “should”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “predict”, “potential”, “continue” or other similar expressions concerning matters that are not historical facts. Actual results may vary from such forward-looking information. Investors should not place undue reliance on forward-looking statements. These forward-looking statements are made as of the date hereof and we assume no obligation to update or revise them to reflect new events or circumstances.

Source: Brompton Exchange Traded Funds

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the Firm
• BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
• Global COVID-19 Memorial Will Honor Pandemic Frontline & Essential Workers